Kentucky BioProcessing (KBP), an American subsidiary of the British tobacco company BAT, has been working on a potential vaccine against COVID-19. Last month, BAT said that it was “hopeful that, with the right partners and support from government agencies, between 1 and 3 million doses of the vaccine could be manufactured per week, beginning in … Continue reading BAT: Potential COVID-19 Plant Based Vaccine Ready for Human Trials